KM Cheung
YOU?
Author Swipe
View article: Best practices in epidermal growth factor receptor T790M testing for advanced non–small-cell lung cancer in Hong Kong
Best practices in epidermal growth factor receptor T790M testing for advanced non–small-cell lung cancer in Hong Kong Open
The T790M mutation in the epidermal growth factor receptor gene causes most acquired resistance to firstor second-line epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small-cell lung cancer. The results of T790M…
View article: Neoadjuvant Treatment of Locally Advanced Rectal Cancer in Elderly Patients: Real-World Experience at a Tertiary Institution
Neoadjuvant Treatment of Locally Advanced Rectal Cancer in Elderly Patients: Real-World Experience at a Tertiary Institution Open
Introduction:The incidence of rectal cancer increases with age.Neoadjuvant radiotherapy, with or without concurrent chemotherapy, has been shown to improve outcomes.Elderly patients are underrepresented in clinical trials.In Hong Kong, the…
View article: Absolute Lymphocyte Count in Cervical Cancer Patients Prior to Definitive Chemoradiotherapy: a Prognostic Indicator?
Absolute Lymphocyte Count in Cervical Cancer Patients Prior to Definitive Chemoradiotherapy: a Prognostic Indicator? Open
Objective: Baseline lymphopenia is associated with poor prognosis in various malignancies.This study aimed to examine the prognostic value of pretreatment lymphocyte count in cervical cancer patients in Hong Kong.Methods: A cohort of 198 c…
View article: Risk Factors for Early Mortality in Head and Neck Cancer Patients Undergoing Definitive Chemoradiation
Risk Factors for Early Mortality in Head and Neck Cancer Patients Undergoing Definitive Chemoradiation Open
Introduction: Head and neck cancer (HNC) afflicts >16,000 people in Hong Kong annually.Non-operative treatment for HNC typically involves radiotherapy (with or without concurrent systemic therapy) and is associated with significant acute t…
View article: Gemcitabine Plus Nanoparticle Albumin-bound Paclitaxel for Patients with Inoperable Pancreatic Cancer: Experience at a Single Oncology Centre
Gemcitabine Plus Nanoparticle Albumin-bound Paclitaxel for Patients with Inoperable Pancreatic Cancer: Experience at a Single Oncology Centre Open
Objective: To review the outcomes of gemcitabine plus nanoparticle albumin-bound (nab)-paclitaxel for patients with inoperable pancreatic cancer.Methods: The data of patients treated with this regimen at a single oncology centre in Hong Ko…
View article: Treatment Outcomes in Patients Receiving Regorafenib for Metastatic Colon Cancer
Treatment Outcomes in Patients Receiving Regorafenib for Metastatic Colon Cancer Open
Objectives: To review the treatment outcomes of patients with chemorefractory metastatic colorectal cancer receiving the multikinase inhibitor regorafenib.Methods: This was a retrospective cohort study including patients who received regor…